Study highlights need for integrated healthcare for the homeless

July 01, 2019

A University of Birmingham study has found alarming evidence of severe mental health problems, substance dependence and alcohol misuse amongst homeless population.

Researchers analysed routinely collected datasets from almost 1,000 patients registered to Birmingham Homeless Healthcare Centre in Birmingham city centre. The study found that nearly one in eight had been offered support for substance dependence and one in five had been offered support for alcohol misuse. A high prevalence of infectious hepatitis C was also identified. The study, funded by Public Health England and West Midlands Combined Authority and published today (July 2nd) in the British Journal of General Practice, also showed nearly one in three of the homeless population attended an Accident and Emergency Department in the preceding 12 months. This equates to nearly 60 times the rate of A&E attendance observed in the general population.

Lead Investigator Dr Vibhu Paudyal, of the University of Birmingham's School of Pharmacy, said: "The study provides compelling evidence about the health problems faced by homeless people.

"Participants, whose average age was 38 years old, had two or more serious chronic medical conditions, a rate comparable to people in their 60s.

"Substance abuse and alcohol dependency were common, as were mental health problems and hepatitis C.

"This study reinforces the need to further expand and diversify specialist services available to the homeless population, particularly preventative services. Further work needs to be done to minimise fragmentation of services and to improve access and experiences around homeless use of mainstream general practices.

"Our previous research has shown that patients highly value the specialist and dedicated services that exist for homeless people such as the one in Birmingham city centre.

"Ill health can be both the cause and consequences of homelessness. Hence, early and opportunistic prevention and treatment of mental health, substance and alcohol dependence can prevent ill health and, for many, the repeat cycle of homelessness.

"These services should be readily accessible and where possible to be offered under one roof as many of these conditions are co-prevalent."

Dr Paudyal said that evidence suggests that retention in long-term treatment of hepatitis C infection is greater when treatment of substance dependence is offered simultaneously. Such multi-disciplinary approach can effectively prevent disease and harm from risky behaviours, improve health outcomes and reduce demand on A&E departments, Dr Paudyal added.

The authors of this study urge GP practices to make registration of homeless people easier, and to provide signposting to specialist homelessness services, where they are available. They want mainstream health services to be flexible and tailored to ensure this population do not face challenges and barriers in accessing care.

Shelter estimates that there are over 320,000 homeless people in the UK, and the number continues to rise.
-end-
For more information please contact Emma McKinney, Communications Manager (Health Sciences), University of Birmingham, Email: e.j.mckinney@bham.ac.uk or tel: +44 (0) 121 414 6681, or contact the press office on +44 (0) 7789 921 165 or pressoffice@contacts.bham.ac.uk

Notes to Editors:

University of Birmingham

Related Hepatitis Articles from Brightsurf:

Busting Up the Infection Cycle of Hepatitis B
Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the ''spiky ball'' that encloses its genetic blueprint.

Liver cancer: Awareness of hepatitis D must be raised
Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma.

Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B.

Anti-hepatitis medicine surprises
A new effective treatment of hepatitis C not only combats the virus, but is also effective against potentially fatal complications such as reduced liver functioning and cirrhosis.

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.

Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.

How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.

High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.

Findings could lead to treatment of hepatitis B
Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

Read More: Hepatitis News and Hepatitis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.